We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$791M
AUM Growth
+$12.6M
Cap. Flow
-$19.3M
Cap. Flow %
-2.44%
Top 10 Hldgs %
45.52%
Holding
139
New
7
Increased
27
Reduced
43
Closed
7

Top Buys

1
GILD icon
Gilead Sciences
GILD
+$11.1M
2
KEY icon
KeyCorp
KEY
+$3.27M
3
UPS icon
United Parcel Service
UPS
+$1.06M
4
SLB icon
SLB Ltd
SLB
+$915K
5
XOM icon
ExxonMobil
XOM
+$579K

Top Sells

1
TMO icon
Thermo Fisher Scientific
TMO
+$9.74M
2
JPM icon
JPMorgan Chase
JPM
+$9.72M
3
MET icon
MetLife
MET
+$6.47M
4
CB icon
Chubb
CB
+$4.94M
5
CVS icon
CVS Health
CVS
+$849K

Sector Composition

1 Financials 25.6%
2 Healthcare 19.03%
3 Technology 16.01%
4 Industrials 13.19%
5 Consumer Discretionary 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CB icon
1
Chubb
CB
$133B
$40.8M 5.16%
299,752
-36,699
-11% -$4.94M
CMCSA icon
2
Comcast
CMCSA
$86.1B
$39.6M 5.01%
1,053,752
-9,590
-0.9% -$356K
AAPL icon
3
Apple
AAPL
$4.89T
$38.8M 4.91%
1,081,404
-6,644
-0.6% -$219K
MSFT icon
4
Microsoft
MSFT
$2.98T
$37.3M 4.72%
566,546
-269
-0% -$17.2K
GE icon
5
GE Aerospace
GE
$361B
$36.6M 4.63%
256,479
+3,718
+1% +$538K
AIG icon
6
American International
AIG
$41.4B
$36.1M 4.56%
578,128
-2,337
-0.4% -$150K
ORCL icon
7
Oracle
ORCL
$358B
$35.9M 4.54%
805,020
-1,131
-0.1% -$47.1K
APTV icon
8
Aptiv
APTV
$12.5B
$34.5M 4.36%
428,885
+1,314
+0.3% +$98.7K
TMO icon
9
Thermo Fisher Scientific
TMO
$202B
$30.6M 3.86%
198,928
-63,701
-24% -$9.74M
DHR icon
10
Danaher
DHR
$145B
$29.9M 3.78%
394,113
+863
+0.2% +$64.2K
UPS icon
11
United Parcel Service
UPS
$99.6B
$29.4M 3.72%
274,385
+9,690
+4% +$1.06M
C icon
12
Citigroup
C
$221B
$27.9M 3.52%
465,684
-11,293
-2% -$668K
CIT
13
DELISTED
CIT Group Inc.
CIT
$27.2M 3.43%
632,703
-18,432
-3% -$781K
CELG
14
DELISTED
Celgene Corp
CELG
$25.7M 3.25%
206,430
+474
+0.2% +$56.7K
MET icon
15
MetLife
MET
$60.3B
$24.5M 3.09%
519,543
-135,735
-21% -$6.47M
AGN
16
DELISTED
Allergan plc
AGN
$24.3M 3.08%
101,856
+202
+0.2% +$47K
DAL icon
17
Delta Air Lines
DAL
$57B
$22.4M 2.83%
487,472
-382
-0.1% -$18.6K
JPM icon
18
JPMorgan Chase
JPM
$912B
$22.1M 2.8%
251,928
-110,126
-30% -$9.72M
GILD icon
19
Gilead Sciences
GILD
$169B
$21.8M 2.75%
320,770
+157,752
+97% +$11.1M
BALL icon
20
Ball Corp
BALL
$16.8B
$20M 2.53%
538,716
+2,216
+0.4% +$82.7K
SLB icon
21
SLB Ltd
SLB
$70.4B
$19.5M 2.47%
249,929
+11,189
+5% +$915K
GOOGL icon
22
Alphabet (Google) Class A
GOOGL
$4.33T
$17.7M 2.24%
417,820
+2,820
+0.7% +$119K
WHR icon
23
Whirlpool
WHR
$2.59B
$17.5M 2.22%
102,413
+51
+0% +$9.06K
GOOG icon
24
Alphabet (Google) Class C
GOOG
$4.32T
$16.7M 2.12%
403,660
-500
-0.1% -$20.5K
JCI icon
25
Johnson Controls International
JCI
$86.2B
$12.5M 1.57%
295,860
+1,389
+0.5% +$58.7K
1
2 3 4 5

Similar funds

NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cannell & Spears's Q1 2017 Portfolio in Review

As of Q1 2017, Cannell & Spears held 139 positions worth $791M, up 1.6% from $779M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cannell & Spears's Q1 2017 filing shows 7 new, 27 increased, 43 reduced and 7 closed positions. Its largest new stake was KeyCorp: 178,634 shares worth $3.18M. The largest sale was Thermo Fisher Scientific, an estimated $9.74M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Technology.

  • Cannell & Spears's largest Q1 2017 buy was KeyCorp: 178,634 shares worth $3.18M.
  • Cannell & Spears added most to Gilead Sciences in Q1 2017, an estimated $11.1M increase.
  • Cannell & Spears's biggest Q1 2017 reduction was Thermo Fisher Scientific, cutting an estimated $9.74M.
  • Cannell & Spears fully exited Kimberly-Clark in Q1 2017, selling an estimated $604K.
  • Cannell & Spears's ten largest holdings make up 46% of its $791M portfolio in Q1 2017.
  • Cannell & Spears opened 7 new positions and closed 7 in Q1 2017.
  • Cannell & Spears's portfolio value rose 1.6% quarter-over-quarter to $791M.

Based on Cannell & Spears's 13F filing for Q1 2017, filed 10 May 2017.